Inogen (INGN) Free Cash Flow (2013 - 2026)
Inogen's (INGN) quarterly Free Cash Flow came in at -$5.2 million in Q1 2026, up 69.43% year-on-year from -$3.1 million in Q1 2025, and down 636.69% on a QoQ basis from $973000.0 in Q4 2025.
Inogen (INGN) Free Cash Flow (2013 - 2026) Analysis & Trends
Inogen (INGN) has 14 years of Free Cash Flow data on file, last reported at -$5.2 million in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 69.43% year-over-year to -$5.2 million in Q1 2026; TTM through Mar 2026 was $2.4 million, a 136.92% increase from a year earlier, with the FY2025 full-year figure at -$9.5 million, down 265.37% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$5.2 million, down from $973000.0 in the prior quarter.
- Over the last five years, Free Cash Flow for INGN reached as high as $5.4 million in Q2 2024 and fell as low as -$19.5 million in Q1 2022.
- Historically, Free Cash Flow has averaged -$3.0 million across 5 years, with a median of -$184000.0 in 2024.
- Across the five-year window, Free Cash Flow plunged 770.94% in 2022 and jumped 673.4% in 2024, its largest moves.
- Year by year, Free Cash Flow stood at -$15.4 million in 2022, then surged by 81.47% to -$2.9 million in 2023, then jumped by 93.55% to -$184000.0 in 2024, then surged by 628.8% to $973000.0 in 2025, then tumbled by 636.69% to -$5.2 million in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$5.2 million in Q1 2026, $973000.0 in Q4 2025, and $2.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Inogen | 172.68 Mn | 62.51 Mn | 37.86 Mn | -5.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.22 Mn |
| Mar 31, 2026 | -5.22 Mn |
| Dec 31, 2025 | 973,000.00 |
| Dec 31, 2025 | 973,000.00 |
| Sep 30, 2025 | 2.37 Mn |
| Sep 30, 2025 | 2.37 Mn |
| Jun 30, 2025 | 4.28 Mn |
| Jun 30, 2025 | 4.28 Mn |
| Mar 31, 2025 | -17.08 Mn |
| Mar 31, 2025 | -17.08 Mn |
| Dec 31, 2024 | -184,000.00 |
| Dec 31, 2024 | -184,000.00 |
| Sep 30, 2024 | 5.32 Mn |
| Sep 30, 2024 | 5.32 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Mar 31, 2024 | -4.85 Mn |
| Mar 31, 2024 | -4.85 Mn |
| Dec 31, 2023 | -2.85 Mn |
| Dec 31, 2023 | -2.85 Mn |